Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma
Status:
Recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
This study is to evaluate the efficacy and safety of Albumin-bound paclitaxel combined with
Toripalimab as first-line/second-line treatment of local advanced or metastatic gastric or
gastroesophageal junction carcinoma.